A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

@article{Morota2011ACE,
  title={A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.},
  author={Kaori Morota and Masatoshi Nakagawa and Rika Sekiya and Philip M. Hemken and Lori Sokoll and Debra Elliott and Daniel Wai-Tin Chan and Barry L. Dowell},
  journal={Clinical chemistry and laboratory medicine},
  year={2011},
  volume={49 4},
  pages={711-8}
}
BACKGROUND Golgi protein-73 (GP73) and fucosylated proteins have been proposed as potential serum markers for liver disease and/or hepatocellular carcinoma (HCC). The purpose of this study was to compare the sensitivity and specificity of serum GP73 and fucosylated hemopexin (Fuc-HPX) with α-fetoprotein (AFP) and with protein induced by the absence of… CONTINUE READING